» Authors » Smriti Ojha

Smriti Ojha

Explore the profile of Smriti Ojha including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 12
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ojha S, Vishwakarma P, Mishra S, Tripathi S
Infect Disord Drug Targets . 2024 Jun; 25(1):e310524230589. PMID: 38831576
Urinary Tract Infection (UTI) is a common bacterial infection that can affect various parts of the urinary system, with symptoms including frequent urination, painful urination, and lower back pain. UTIs...
2.
Sharma D, Pooja , Nirban S, Ojha S, Kumar T, Jain N, et al.
AAPS PharmSciTech . 2023 Dec; 24(8):252. PMID: 38049695
Tuberculosis (TB) is among the top 10 infectious diseases worldwide. It is categorized among the leading killer diseases that are the reason for the death of millions of people globally....
3.
Mishra S, Vishwakarma P, Tripathi M, Ojha S, Tripathi S
Curr Diabetes Rev . 2023 Nov; 20(7):e271023222871. PMID: 37929721
Diabetic retinopathy is a common complication of diabetes that affects the eyes and can lead to severe vision loss or blindness if left untreated. Chronic hyperglycemia destroys the blood vessels...
4.
Singh A, Mishra S, Sharma S, Ojha S, Yagnik S, Pandey S
Curr Cancer Drug Targets . 2023 Sep; 23(11):879-888. PMID: 37655629
One of the most important health problems in the world today is cancer. The World Health Organization (WHO) reported that it results in 8.9 million deaths annually. Malignant tumours and...
5.
Kumar A, Sharma S, Mishra S, Ojha S, Upadhyay P
Anticancer Agents Med Chem . 2023 Apr; 23(13):1499-1505. PMID: 37070442
Nature is the chief source of various remedies which are used to cure various diseases. Boswellic acid (BA) is a secondary metabolite from the pentacyclic terpenoid compound groups that are...
6.
Ojha S, Kumar B
Adv Pharm Bull . 2018 Jul; 8(2):225-233. PMID: 30023324
The objective of this study was to synthesize and statistically optimize dimethyl fumarate (DMF) loaded solid lipid nanoparticles (SLNs) for better management of multiple sclerosis (MS). SLNs were formulated by...